AIP
FENC icon

Ameritas Investment Partners’s Fennec Pharmaceuticals FENC Stock Holding History

Ameritas Investment Partners’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.22K Hold
1,499
– – ﹤0.01% 2888
2025
Q4 		$11.5K Hold
1,499
– – ﹤0.01% 2867
2025
Q3 		$14K Hold
1,499
– – ﹤0.01% 2835
2025
Q2 		$12.4K Hold
1,499
– – ﹤0.01% 2892
2025
Q1 		$9.13K Hold
1,499
– – ﹤0.01% 2851
2024
Q4 		$9.47K Hold
1,499
– – ﹤0.01% 2919
2024
Q3 		$7.5K Hold
1,499
– – ﹤0.01% 2989
2024
Q2 		$9.16K Hold
1,499
– – ﹤0.01% 2954
2024
Q1 		$16.7K Hold
1,499
– – ﹤0.01% 2633
2023
Q4 		$16.8K Hold
1,499
– – ﹤0.01% 2657
2023
Q3 		$11.3K Hold
1,499
– – ﹤0.01% 2793
2023
Q2 		$13.2K Buy
+1,499
New +$12.5K ﹤0.01% 2791
2021
Q2 		– Sell
-1,908
Closed -$12K – 3114
2021
Q1 		$12K Hold
1,908
– – ﹤0.01% 2771
2020
Q4 		$14K Hold
1,908
– – ﹤0.01% 2644
2020
Q3 		$12K Hold
1,908
– – ﹤0.01% 2630
2020
Q2 		$16K Buy
+1,908
New +$14.2K ﹤0.01% 2462
2019
Q2 		– Sell
-914
Closed -$4K – 3069
2019
Q1 		$4K Hold
914
– – ﹤0.01% 2880
2018
Q4 		$6K Hold
914
– – ﹤0.01% 2815
2018
Q3 		$7K Hold
914
– – ﹤0.01% 2913
2018
Q2 		$10K Buy
+914
New +$10.8K ﹤0.01% 2834

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Ameritas Investment Partners's FENC Position: Q1 2026 in Review

Ameritas Investment Partners held its Fennec Pharmaceuticals (FENC) position steady in Q1 2026 at 1,499 shares worth $9.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2888.

Ameritas Investment Partners first reported a position in FENC in Q2 2018 and has held it in 20 quarters since. The position peaked at $16.8K in Q4 2023. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • Ameritas Investment Partners held 1,499 shares of Fennec Pharmaceuticals worth $9.22K as of Q1 2026.
  • Ameritas Investment Partners left its Fennec Pharmaceuticals share count unchanged in Q1 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2888 holding.
  • Ameritas Investment Partners first reported a position in Fennec Pharmaceuticals in Q2 2018 and has held it in 20 quarters since.
  • Ameritas Investment Partners's Fennec Pharmaceuticals position peaked at $16.8K in Q4 2023.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.